Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis–No

MT Wallin - Multiple Sclerosis Journal, 2018 - journals.sagepub.com
The success of B cell–directed therapy in patients with multiple sclerosis (MS) has been
highlighted and demonstrates the essential role these cells have in the pathogenesis of MS …
被引用次数：10 相关文章

[引用][C] Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis-No

MT Wallin - Multiple sclerosis (Houndmills, Basingstoke …, 2018 - pubmed.ncbi.nlm.nih.gov

Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis-No.

MT Wallin - Multiple Sclerosis (Houndmills, Basingstoke, England), 2018 - europepmc.org
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis - No. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …